Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson's disease: the APOKADO study

F Zagnoli, A Leblanc, I Viakhireva-Dovganyuk… - Journal of Neural …, 2023 - Springer
Continuous subcutaneous apomorphine infusion (CSAI) is used to treat patients with
Parkinson's disease (PD) who are experiencing motor fluctuations. However, the need to …

[HTML][HTML] 4.1 People with Parkinson's disease: how needs change with disease stage

S Rota, C Farrell, A Rizos… - Where are We …, 2023 - ncbi.nlm.nih.gov
“When you are diagnosed with Parkinson's disease, motor symptoms are usually not the
main issue. The problem related with its diagnosis is the combination of the known with the …